Ingevity (NGVT) last issued guidance on February 25, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.80 - $5.20, compared to a consensus EPS estimate of $4.76. Ingevity also guided revenue in the range of $1.10B - $1.20B for the period.
Compared to prior guidance, Ingevity lowered its revenue forecast from a prior range of $1.25B - $1.35B.
Ingevity has issued 17 guidance updates between May 4, 2022 and February 25, 2026. During this period, the company raised its outlook 2 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by Ingevity, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Ingevity (NGVT) was reported on February 25, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $4.80 to $5.20, compared to the estimated EPS of $4.76. Additionally, Ingevity forecasted revenue between $1.10B and $1.20B for the period.
Ingevity (NGVT) guided EPS in the range of $4.80 to $5.20 for the fiscal year 2026. The consensus analyst EPS estimate is $4.76.
Ingevity (NGVT) guided revenue in the range of $1.10B to $1.20B for the fiscal year 2026.
Ingevity (NGVT) lowered its revenue guidance from a prior range of $1.25B - $1.35B to $1.10B - $1.20B for the fiscal year 2026.
Ingevity (NGVT) last issued guidance on February 25, 2026 for the fiscal year 2026.